PAG
ALBO

Private Advisor Group’s Albireo Pharma Inc ALBO Stock Holding History

Private Advisor Group’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12
Closed – – 3706
2020
Q2 		$0 Buy
+12
New +$283 ﹤0.01% 3960
2014
Q4 		– Sell
-433
Closed -$22K – 1325
2014
Q3 		$22K Hold
433
– – ﹤0.01% 1133
2014
Q2 		$28K Hold
433
– – ﹤0.01% 881
2014
Q1 		$35K Buy
+433
New +$39.4K ﹤0.01% 790

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Private Advisor Group's ALBO Position: Q3 2020 in Review

Private Advisor Group sold out of Albireo Pharma Inc (ALBO) in Q3 2020, closing a stake of 12 shares.

Private Advisor Group first reported a position in ALBO in Q1 2014 and held it in 4 quarters. The position peaked at $35K in Q1 2014. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2020.

  • Private Advisor Group reported no remaining Albireo Pharma Inc position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 12 Albireo Pharma Inc shares in Q3 2020.
  • Private Advisor Group first reported a position in Albireo Pharma Inc in Q1 2014 and held it in 4 quarters.
  • Private Advisor Group's Albireo Pharma Inc position peaked at $35K in Q1 2014.
  • 108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.